Wegovy (semaglutide)
Patient Assistance Program Guide — Novo Nordisk Patient Assistance Program (PAP)
Do You Qualify?
Income
Up to $60,240 for a single person
Insurance
Must be uninsured or have no coverage for the medication through any private or government-sponsored program (some Medicare restrictions apply; Wegovy is generally excluded from PAP if not covered by the specific Medicare plan).
Residency
U.S. resident or legal resident with a valid address
Income Limits (400% FPL)
Calculated based on 400% of the 2025 Federal Poverty Level. Total household income must be at or below this amount.
Based on 2025 HHS Federal Poverty Level guidelines.
# Wegovy (Semaglutide) Patient Assistance Program Guide
Novo Nordisk Patient Assistance Program (PAP) — Powered by RX Advantages
---
Who Qualifies for the Novo Nordisk Patient Assistance Program (PAP)?
If you need Wegovy but cannot afford it, the Novo Nordisk Patient Assistance Program (PAP) may be able to get it to you at no cost. This program is designed for people who meet income and insurance requirements set by Novo Nordisk, the drug's manufacturer.
To start, your total household income must be at or below $60,240 per year if you live alone. Higher limits apply for larger households.
On the insurance side, you must be uninsured or have no coverage for Wegovy through any private or government-sponsored insurance plan. If your insurance covers Wegovy — even partially — you may not qualify for this program, though other savings options may still be available to you.
---
About Wegovy (Semaglutide)
Wegovy is an injectable prescription medication made by Novo Nordisk. It belongs to a class of drugs called GLP-1 receptor agonists. The U.S. Food and Drug Administration (FDA) has approved Wegovy for two uses in adults: chronic weight management and reducing the risk of serious heart events in people who have established cardiovascular disease and are living with obesity or overweight.
Without insurance or financial assistance, Wegovy carries a high list price that puts it out of reach for many patients. The Novo Nordisk PAP exists specifically to help people who need this medication but lack the coverage or income to pay for it on their own.
---
Income Eligibility: Full Breakdown
The Novo Nordisk PAP uses income limits based on 400% of the 2025 Federal Poverty Level. Your total household income must be at or below the limit for your household size:
| Household Size | Max Annual Income |
|---|---|
| 1 person | $60,240 |
| 2 persons | $81,760 |
| 3 persons | $103,280 |
| 4 persons | $124,800 |
If your household has more than four people, the income limit increases with each additional member. Contact the program directly at (866) 310-7549 to confirm the threshold for your household size.
To verify your income, you will typically need to provide your most recent federal tax return (Form 1040), a W-2, or three consecutive recent pay stubs. If you are self-employed or have irregular income, Novo Nordisk may ask for additional documentation.
If your income is slightly above the limit, you may not qualify for this program. However, you should still explore the savings card and other options described in the final section of this guide — being just over the threshold does not mean you have no options.
---
Insurance Requirements Explained
Understanding how your insurance affects eligibility is important before you apply.
---
Step-by-Step: How to Apply
Follow these steps to apply for the Novo Nordisk PAP for Wegovy:
1. Gather your documents first. You will need: a completed and signed application (both the patient section and the prescriber section), proof of income (most recent Form 1040, W-2, or three consecutive pay stubs), and a valid prescription for Wegovy from your healthcare provider.
2. Choose your application method. You can apply online, by phone, or by fax.
- Online: Visit https://www.novocare.com/elp/pap/wegovy to complete and submit your application digitally.
- By phone: Call (866) 310-7549 to get help completing your application or to ask questions about eligibility.
- By fax: Submit completed forms to (866) 441-4190.
3. Have your prescriber complete their section. Your doctor or their office staff must fill out and sign the prescriber portion of the application. Many offices are familiar with this process — ask them to complete it as soon as possible to avoid delays.
4. Submit all documents together. Incomplete applications are a common reason for delays. Make sure income documentation and the prescription are included with your application.
5. Wait for confirmation. After submission, Novo Nordisk will review your application and contact you or your prescriber with a decision.
---
What to Expect: Timeline and Delivery
Once your complete application is submitted, processing typically takes 7 to 10 business days. Novo Nordisk will notify you or your prescriber of the approval decision.
If approved, Wegovy will be shipped directly to your home address — you do not need to pick it up at a pharmacy. Make sure someone is available to receive temperature-sensitive medication if required.
Your approval is not permanent. The program requires annual reauthorization, which means you will need to reapply and submit updated income documentation once a year to continue receiving Wegovy at no cost. Set a reminder before your approval period ends so there is no interruption in your supply.
---
Alternatives If You Don't Qualify
If you do not meet the PAP requirements, you still have options.
Biosimilars: There are currently no FDA-approved biosimilar versions of Wegovy (semaglutide). This means a lower-cost generic alternative is not yet available.
Manufacturer savings card (insured patients): If you have private insurance that covers Wegovy, Novo Nordisk offers a savings card that may reduce your out-of-pocket costs. Visit https://www.wegovy.com/coverage-and-savings/save-on-wegovy.html to check your eligibility.
State Pharmaceutical Assistance Programs (SPAPs): Many states offer their own prescription assistance programs, particularly for residents who are seniors or have disabilities. Search for your state's program through your state health department website.
NeedyMeds.org: This free, independent database lists hundreds of assistance programs by drug name and condition. Visit https://www.needymeds.org to search for additional options that may apply to your situation.
---
*This guide is for informational purposes only and does not constitute medical or legal advice. Eligibility determinations are made solely by Novo Nordisk. Program terms may change — verify current requirements at [https://www.novocare.com/obesity/products/wegovy/let-us-help/pap.html](https://www.novocare.com/obesity/products/wegovy/let-us-help/pap.html) before applying.*
---
Documents You'll Need
If You Don't Qualify for the Assistance Program
Manufacturer Savings Card (for insured patients)
Novo Nordisk offers a savings card that may reduce your out-of-pocket cost if you have commercial insurance. Ask your prescriber or pharmacist for current savings card details.
Common Questions
Processing typically takes 7 to 10 business days after Novo Nordisk receives your complete application. Submitting all required documents — including the prescriber section and proof of income — at the same time helps avoid delays.
Yes. If you have insurance but your plan does not provide any coverage for Wegovy, you may still qualify for the PAP. You should confirm with your insurance company that Wegovy is excluded from your plan before applying.
Yes. The Novo Nordisk PAP requires annual reauthorization. Before your current approval period ends, you will need to submit a new application along with updated income documentation to continue receiving Wegovy through the program.
If your income exceeds the program threshold, you may not qualify for the PAP. However, you may still be eligible for the Novo Nordisk savings card if you have private insurance, or you can search NeedyMeds.org for other assistance programs.
If you are approved, Wegovy is shipped directly to your home address. You do not need to go to a pharmacy to pick it up.
Ready to Apply for Wegovy Assistance?
RX Advantages handles the entire Novo Nordisk Patient Assistance Program (PAP) application on your behalf — paperwork, physician coordination, and refill tracking. It takes about 15 minutes to get started.
No SSN required on the web form · From $49.95/month